Myomo/$MYO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Myomo
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Ticker
$MYO
Sector
Primary listing
AMEX
Employees
195
Headquarters
Website
Myomo Metrics
BasicAdvanced
$55m
-
-$0.39
1.39
-
Price and volume
Market cap
$55m
Beta
1.39
52-week high
$2.83
52-week low
$0.61
Average daily volume
987k
Financial strength
Current ratio
2.734
Quick ratio
2.187
Long term debt to equity
204.04
Total debt to equity
210.649
Interest coverage (TTM)
-12.23%
Profitability
EBITDA (TTM)
-13.046
Gross margin (TTM)
65.96%
Net profit margin (TTM)
-36.69%
Operating margin (TTM)
-34.07%
Effective tax rate (TTM)
-3.81%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
-22.61%
Return on equity (TTM)
-98.53%
Valuation
Price to revenue (TTM)
1.329
Price to book
6.08
Price to tangible book (TTM)
7.56
Price to free cash flow (TTM)
-3.186
Free cash flow yield (TTM)
-31.39%
Free cash flow per share (TTM)
-0.446
Growth
Revenue change (TTM)
6.68%
Earnings per share change (TTM)
132.23%
3-year revenue growth (CAGR)
39.64%
10-year revenue growth (CAGR)
50.28%
3-year earnings per share growth (CAGR)
-24.95%
10-year earnings per share growth (CAGR)
-43.80%
Myomo News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs